Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia

Journal of Clinical Investigation

Volumn 110, Issue 7, 2002, Pages 993-1002

  Synnestvedt, Kristin ^a   Furuta, Glenn T ^b   Comerford, Katrina M ^a   Louis, Nancy ^a   Karhausen, Jorn ^a   Eltzschig, Holger K ^a   Hansen, Karl R ^c   Thompson, Linda F ^d   Colgan, Sean P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; ECTO 5' NUCLEOTIDASE; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; 5' NUCLEOTIDASE; ADENOSINE TRIPHOSPHATASE; APYRASE; CD39 ANTIGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA BINDING PROTEIN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LEUKOCYTE ANTIGEN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CELL CULTURE; ENZYME REGULATION; EPITHELIUM CELL; INTESTINE EPITHELIUM; INTESTINE MUCOSA PERMEABILITY; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA ANALYSIS; TRANSCRIPTION REGULATION; BIOSYNTHESIS; CELL HYPOXIA; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTESTINE MUCOSA; METABOLISM; PERMEABILITY; PHYSIOLOGY;

5'-NUCLEOTIDASE; ADENOSINE TRIPHOSPHATASES; ANTIGENS, CD; APYRASE; CELL HYPOXIA; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTESTINAL MUCOSA; NUCLEAR PROTEINS; PERMEABILITY; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 85047685683     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215337     Document Type: Article

References (60)

1. Pearson, J.D., and Gordon, J.L. 1985. Nucleotide metabolism by endothelium. Annu. Rev. Physiol. 47:617-627.
2. Zimmermann, H., and Braun, N. 1999. Ecto-nucleotidases: molecular structures, catalytic properties, and functional roles in the nervous system. Prog. Brain Res. 120:371-385.
3. Strohmeier, G.R., et al. 1997. Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia. J. Clin. Invest. 99:2588-2601.
4. 2B receptor activation. J. Exp. Med. 188:1433-1443.
5. Stiles, G.L. 1992. Adenosine receptors. J. Biol. Chem. 267:6451-6454.
6. Mertens, S., Noll, T., Spahr, R., Krutzfeldt, A., and Piper, H.M. 1990. Energetic response of coronary endothelial cells to hypoxia. Am. J. Physiol. 258:H689-H694.
7. Madara, J.L., et al. 1993. 5′-Adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. J. Clin. Invest. 91:2320-2325.
8. Airas, L., et al. 1995. CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73. J. Exp. Med. 182:1603-1608.
9. Linden, J. 2001. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41:775-787.
10. Kitakaze, M., et al. 1999. Adenosine and cardioprotection in the diseased heart. Jpn. Circ. J. 63:231-243.
11. Hansen, K.R., Resta, R., Webb, C.F., and Thompson, L.F. 1995. Isolation and characterization of the promoter of the human 5′-nucleotidase (CD73)-encoding gene. Gene. 167:307-312.
12. Montminy, M. 1997. Transcriptional regulation by cyclic AMP. Annu. Rev Biochem. 66:807-822.
13. Kobayashi, S., Zimmermann, H., and Millhorn, D.E. 2000. Chronic hypoxia enhances adenosine release in rat PC12 cells by altering adenosine metabolism and membrane transport. J. Neurochem. 74:621-632.
14. Taylor, C.T., Furuta, G.T., Synnestvedt, K., and Colgan, S.P. 2000. Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia. Proc Natl. Acad. Sci. USA. 97:12091-12096.
15. Furuta, G.T., et al. 2001. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J. Exp. Med. 193:1027-1034.
16. Zünd, G., et al. 1996. Hypoxia enhances stimulus-dependent induction of E-selectin on aortic endothelial cells. Proc. Natl. Acad. Sci. USA. 93:7075-7080.
17. Lockhart, D.J., et al. 1996. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14:1675-1680.
18. Higuchi, R., Fockler, C., Dollinger, G., and Watson, R. 1993. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology. 11:1026-1030.
19. Pfaffl, M.W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:2002-2007.
20. Lawrence, D.W., Comerford, K.M., and Colgan, S.P. 2002. Role of VASP in reestablishment of epithelial tight junction assembly after Ca2+ switch. Am. J. Physiol. Cell Physiol. 282:C1235-C1245.
21. Parkos, C.A., Colgan, S.P., Delp, C., Arnaout, M.A., and Madara, J.L. 1992. Neutrophil migration across a cultured epithelial monolayer elicits a biphasic resistance response representing sequential effects on transcellular and paracellular pathways. J. Cell Biol. 117:757-764.
22. Dharmsathaphorn, K., and Madara, J.L., 1990. Established intestinal cell lines as model systems for electrolyte transport studies. Methods Enzymol. 192:354-389.
23. 3. J. Clin. Invest 105:577-587.
24. Ueda, K., Pastan, I., and Gottesman, M.M. 1987. Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene. J. Biol. Chem. 262:17432-17436.
25. Chen, C.J., et al. 1990. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J. Biol. Chem. 265:506-514.
26. Napolitano, L.M., Koruda, M.J., Meyer, A.A., and Baker, C.C. 1996. The impact of femur fracture with associated soft tissue injury on immune function and intestinal permeability. Shock. 5:202-207.
27. Skinner, M.R., and Marshall, J.M. 1996. Studies on the roles of ATP, adenosine and nitric oxide in mediating muscle vasodilatation induced in the rat by acute systemic hypoxia. J. Physiol. 495:553-560.
28. Evans, S.M., et al. 2000. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res. 60:2018-2024.
29. Narravula, S., and Colgan, S.P. 2001. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. J. Immunol 166:7543-7548.
30. Narravula, S., Lennon, P.F., Mueller, B.U., and Colgan, S.P. 2000. Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function. J. Immunol. 165:5262-5268.
31. Friedman, G.B., Taylor, C.T., Parkos, C.A., and Colgan, S.P. 1998. Epithelial permeability induced by neurtrophil transmigration is potentiated by hypoxia: role of intracellular cAMP. J. Cell. Physiol. 176:76-84.
32. Thompson, L.F., et al. 1990. Production and characterization of monoclonal antibodies to the glycosyl phosphatydylinositol-anchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73). Tissue Antigens. 35:9-19.
33. Jamal, Z., Afkham-Ebrahimi, A., and Saggerson, E.D. 1988. A novel assay for 5′ectonucleotidase using 1,N6-etheno-AMP as substrate, and comments on the properties of the reaction product, ethenoadenosine. Biochem. J. 250:369-373.
34. Wang, T. F., and Guidotti, G. 1996. CD39 is an ecto-(Ca2+,Mg2+)-apyrase. J. Biol. Chem. 271:9898-9901.
35. Beitner-Johnson, D., and Millhorn, D.E. 1998. Hypoxia induces phosphorylation of the cyclic AMP response element-binding protein by a novel signaling mechanism. J. Biol. Chem. 273:19834-19839.
36. Taylor, C.T., Fueki, N., Agah, A., Hershberg, R.M., and Colgan, S.P. 1999. Critical role of cAMP response element binding protein expression in hypoxia-elicited induction of epithelial TNFaα. J. Biol. Chem. 274:19447-19450.
37. Li, Z., et al. 2000. Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science. 287:1046-1049.
38. Hirsch, E., et al. 2000. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science. 287:1049-1053.
39. Zimmerman, H. 1992. 5′-Nucleotidase: molecular structure and functional aspects. Biochem. J. 285:345-365.
40. Imai, S., Nakazawa, M., Imai, H., and Jin, H. 1987. 5′-Nucleotidase inhibitors and the myocardial reactive hyperemia and adenosine content. In Topics and perspectives in adenosine research. E. Gerlach and B.F. Becker, editors. Springer-Verlag. Berlin, Germany. 416-426.
41. Minamino, T., et al. 1996. Cardioprotection due to preconditioning correlates with increased ecto-5′-nucleotidase activity. Am. J. Physiol. 270:H238-H244.
42. de Jonge, R., Bradamante, S., and de Jong, J.W. 1998. Cardioprotection by ischemic preconditioning. Role of adenosine and glycogen. Adv. Exp. Med. Biol. 431:279-282.
43. Schiele, J.O., and Scwabe, U. 1994. Characterization of the adenosine receptor in microvascular coronary endothelial cells. Eur. J. Pharmacol. 269:51-58.
44. 2A-adenosine receptor on primary human endothelial cells. J. Biol. Chem. 272:5792-5799.
45. Iwamoto, T., et al. 1994. Identification of the adenosine A2 receptor-cAMP system in human aortic endothelial cells. Biochem. Biophys. Res. Commun. 199:905-910.
46. 2-adenosine receptor stimulation increases macromolecular permeability of coronary endothelial cells. Am. J. Physiol. 262:H1174-H1181.
47. Wang, G.L., Jiang, B.H., Rue, E.A., and Semenza, G.L. 1995. Hypoxiainducible factor 1 is a basic-helix-loop-PAS heterodimer regulated by cellular oxygen tension. Proc. Natl. Acad. Sci. USA. 92:5510-5514.
48. Wang, G.L., and Semenza, G.L. 1995. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270:1230-1237.
49. Semenza, G.L. 2000. HIF-1 and human disease: one highly involved factor. Genes Dev. 14:1983-1991.
50. Semenza, G.L. 1998. Hypoxia-inducibie factor 1: master regulator of O2 homeostasis Curr. Opin. Genet. Dev. 8:588-594.
51. Heinemeyer, T., et al. 1998. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26:362-367.
52. Tarumoro, T., et al. 2000. N(G)-monomethyl-L-arginine inhibits erythropoietin gene expression by stimulating GATA-2. Blood. 96:1716-1722.
53. De Maria, R., et al. 1999. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 401:489-493.
54. Comerford, K.M., et al. 2002. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62:3387-3394.
55. Panwala, C.M., Jones, J.C., and Viney, J.L. 1998. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J. Immunol. 161:5733-5744.
56. Plesner, L. 1995. Ecto-ATPases: identities and functions. Int. Rev. Cytol. 158:141-214.
57. Marcus, A.J., et al. 1995. Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions. Thromb. Haemost. 74:213-217.
58. Pinsky, D.J., & et al. 2002. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J. Clin. Invest. 109:1031-1040. doi:10.1172/JCI200210649.
59. Comerford, K.M., Lawrence, D.W., Synnestvedt, K., Levi, B.P., and Colgan, S.P. 2002. Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junctional permeability. FASEB J. 16:583-585.
60. Sheridan, W.G., Lowndes, R.H., and Young, H.L. 1990. Intraoperative tissue oximetry in the human gastrointestinal tract. Am. J. Surg. 159:314-319.